학술논문
Low-burden TP53 mutations represent frequent genetic events in CLL with an increased risk for treatment initiation
Document Type
Artikel
Author
Laszlo, T; Kotmayer, L; Fesus, V; Hegyi, L; Grof, S; Nagy, A; Kajtar, B; Balogh, A; Weisinger, J; Masszi, T; Nagy, Z; Farkas, P; Demeter, J; Istenes, I; Sazsz, R; Gergely, L; Sulak, A; Borbenyi, Z; Levai, D; Schneider, T; Pettendi, P; Bodai, E; Szerafin, L; Rejto, L; Batai, A; Domotor, MA; Santa, H; Plander, M; Szendrei, T; Hamed, A; Lazar, Z; Pauker, Z; Radvanyi, G; Kiss, A; Korosmezey, G; Jakucs, J; Dombi, PJ; Simon, Z; Klucsik, Z; Gurzo, M; Tiboly, M; Vidra, T; Ilonczai, P; Bors, A; Andrikovics, H; Egyed, M; Szekely, T; Masszi, A; Alpar, D; Matolcsy, A; Bodor, C
Source
The journal of pathology. Clinical research. 10(1):e351
Subject
Language
English
English
English
ISSN
2056-4538